Bridget Wagner, PhD
Director, Pancreatic Cell Biology and Metabolic Disease, Institute Scientist, Broad Institute, MIT and Harvard
Bridget Wagner is an Institute scientist at the Broad Institute, and the director of Pancreatic Cell Biology and Metabolic Disease in the Chemical Biology and Therapeutic Sciences Program. Her group's research focuses on the chemical biology of diabetes, modulating diabetes-related processes with small molecules. This work involves cell-based screening and analytical techniques that she has developed and used for fifteen years of small-molecule discovery. Bridget received an AB from Harvard College and a PhD from the Department of Molecular and Cellular Biology at Harvard University, working with Stuart Schreiber on developing probe-discovery efforts in an academic setting. Wagner has had an instrumental role in the development of the Broad Chemical Biology Program from its inception in 2003.